Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 30, 2021

View Archived Issues

Glutamine promotes antibiotic uptake to kill MDR bacteria

NeoPhore patents DNA mismatch repair protein Mlh1/mismatch repair endonuclease PMS2 inhibitors

New transcriptional enhancer factor (TEAD) inhibitors identified at the Dana-Farber Cancer Institute

GB005 discovers Bruton tyrosine kinase inhibitors

New psychosine receptor modulators patented by Pathios Therapeutics

Merck & Co. divulges dual Toll-like receptor 7/8 agonists

Prolyl-tRNA synthetase linked to poor prognosis in multiple myeloma

Vaginal film loaded with hexavalent antisperm IgG shows potential as nonhormonal contraception

Bovine/human parainfluenza virus 3 vector SARS-CoV-2 vaccine shows promise in hamster model

Peripheral delivery of the brain permeable AMPK activator R-481 raises glycemia in rats

High-throughput screening assay to identify inhibitors of SARS-CoV-2 Mac1 macrodomain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.